Tumor angiogenesis and its inhibitors
Shibuya, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 149-153
2012
ISSN/ISBN: 0047-1852 PMID: 23513829 Document Number: 656433
Document emailed within 1 workday
Related Documents
Ono, M.; Kuwano, M. 2001: Tumor angiogenesis and tumor angiogenesis inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(5): 584-590Miszczak-Zaborska, E.; Smolarek, M.; Bartkowiak, J. 2010: Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors Postepy Biochemii 56(1): 61-66
Yamaguchi, K.; Ogawa, K.; Katsube, T.; Shimao, K.; Konno, S.; Shimakawa, T.; Yoshimatsu, K.; Naritaka, Y.; Yagawa, H.; Hirose, K. 2005: Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis Anticancer Research 25(2a): 847-851
Ghosh, S.; Roy, S.; Banerjee, M.; Maity, P. 2004: Modulation of tumor induced angiogenesis in Ehrlich ascites tumor Journal of Experimental and Clinical Cancer Research: Cr 23(4): 681-690
Okada-Ban, M.; Grassi, M.; Plouet, J.; Thiery, J.P.; Jouanneau, J. 1999: Impact on tumor angiogenesis and tumor progression of expression of the 18 kd and 24 kd isoforms of FGF-2 Pathologie-Biologie 47(4): 375-379
Dredge, K.; Dalgleish, A.G.; Marriott, J.B. 2003: Angiogenesis inhibitors in cancer therapy Current Opinion in Investigational Drugs 4(6): 667-674
Venook, A.P.; Venook, A.P. 2015: The value and effectiveness of angiogenesis inhibitors for colorectal cancer Clinical Advances in Hematology and Oncology: H&o 13(9): 561-563
Yoysungnoen, B.; Bhattarakosol, O.; Changtam, C.; Patumraj, S. 2016: Combinational Treatment Effect of Tetrahydrocurcumin and Celecoxib on Cervical Cancer Cell-Induced Tumor Growth and Tumor Angiogenesis in Nude Mice Journal of the Medical Association of Thailand 99 Suppl. 4: S23-S31
Giles, F.J. 2002: The emerging role of angiogenesis inhibitors in hematologic malignancies Oncology 16(5 Suppl 4: 23-29
Fiedler, W.; Staib, P.; Kuse, R.; Dührsen, U.; Flasshove, M.; Cavalli, F.; Hossfeld, D.K.; Berdel, W.E. 2001: Role of angiogenesis inhibitors in acute myeloid leukemia Cancer Journal 7(Suppl 3): S129-S133
Reardon, D.A. 2014: Update on the use of angiogenesis inhibitors in adult patients with brain tumors Clinical Advances in Hematology and Oncology: H&o 12(5): 293-303
Maeshima, Y.; Makino, H. 2010: The role of pro-angiogenic factors and angiogenesis inhibitors in diabetic nephropathy Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 396-400
Li, W.W.; Li, V.W.; Brainerd, N.; Fagen, S.J. 2002: Global development of angiogenesis inhibitors for cancer: principles, progress and new paradigms Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(Suppl 1): 50-58
Fotsis, T.; Pepper, M.S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Schweigerer, L. 1997: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis Cancer Research 57(14): 2916-2921
Green, L.J..; Yamauchi, P.S..; Kircik, L.H.. 2019: Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients with Psoriasis Journal of Drugs in Dermatology: Jdd 18(8): 776-788
McKinnon, C. 1999: Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents Idrugs: the Investigational Drugs Journal 2(7): 624-628
Christofferson, R. 1998: Angiogenesis inhibitors in advanced cancer. many current clinical trials show promising results Lakartidningen 95(20): 2349-2354
Zarrouk, K. 1978: The tumor angiogenesis factor (TAF) Archives de l'Institut Pasteur de Tunis 55(3): 247-273
Lind, J.S.W.; Herder, G.J.M.; Smit, E.F. 2008: New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis Nederlands Tijdschrift Voor Geneeskunde 152(16): 928-932
Oikawa, T. 1998: Control of tumor-related angiogenesis Human Cell 11(4): 201-206